Medicare’s DRG-based inpatient payment and expiring add-on mechanism shift CGT financial risk to hospitals once temporary new ...

In "Why Payers Demand Comparative Evidence for Adjunctive MDD Therapies," Leslie Citrome, MD, MPH opens this series by unpacking why ...

Ahead of the 2026 Patient-Centered Oncology Care ® (PCOC) conference, taking place September 24-25 in Nashville, Tennessee, Stephen "Fred" Divers, MD, of the Genesis Cancer and Blood Institute and the ...

Pooled data from ~29,000 surgically treated T1 cases showed higher nodal involvement in early-onset disease, with odds of metastasis nearly doubled versus older patients. A T1 colorectal tumor is the ...

Within polycythemia vera, patients can be iron deficient while continuing to produce too many red blood cells, explains ...

Lung cancer incidence decreased 3.5%/year in males and 1.9%/year in females during 2018–2022, alongside a two-thirds increase ...

Stephen “Fred” Divers, MD, discusses findings showing community oncology delivers outcomes comparable with academic care for breast cancer and NSCLC. In part 1 of his interview with The American ...

Out-of-pocket spending, defined as co-payments, coinsurance, and deductibles standardized to a 30-day supply, was split into ...

New ASCO 2026 real-world data compares safety and outcomes between FACT-accredited and non-accredited centers, challenging ...

Pessia’s Woodlands practice relies on proximity to a partner hospital. “We’re lucky because Memorial Hermann is literally right across the parking lot, so we can transfer the patient over there fairly ...

For Bhavana Bhatnagar, DO, delivering bispecifics and CAR T-cell therapy requires infrastructure, education, SOPs, and experienced academic colleagues.

All 50 states have applied for CMS's GENEROUS Model, a Medicaid drug pricing program expected to save $64.3 billion over the next decade. CMS recently announced that all 50 states, plus the District ...